Vivek Ramaswamy, Director at Arbutus Biopharma, holds 16.07M shares in Arbutus Biopharma (Ticker: ABUS), holds ― shares in Sio Gene Therapies (Ticker: SIOX), holds 51.93M shares in Roivant Sciences (Ticker: ROIV). Most recently, Vivek Ramaswamy Bought ― shares of Arbutus Biopharma on Mar 16, 2015 for an estimated value of ―.
What is the percentage of profitable transactions made by Vivek Ramaswamy?
The percentage of profitable transactions made by Vivek Ramaswamy is 0%.
What is the average return per transaction made by Vivek Ramaswamy?
The average return per transaction made by Vivek Ramaswamy is -42.60%.
What stocks does Vivek Ramaswamy hold?
Vivek Ramaswamy holds: ABUS, SIOX, ROIV stocks.
What was Vivek Ramaswamy’s latest transaction?
Vivek Ramaswamy latest transaction was an Informative Buy of ―.
What was Vivek Ramaswamy's most profitable transaction?
Vivek Ramaswamy’s most profitable transaction was an Informative Sell of ROIV stock on January 3, 2024. The return on the trade was -9.30%.
What is Vivek Ramaswamy's role in Arbutus Biopharma?
Vivek Ramaswamy's role in Arbutus Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.